Seres Therapeutics, Inc. announced that Marella Thorell will join as Executive Vice President and Chief Financial Officer (CFO), as of March 25th, 2024, following David Arkowitz?s retirement. Prior to joining Seres, she served in executive positions with Evelo Biosciences, Centessa Pharmaceuticals, Palladio Biosciences and Realm Therapeutics.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 USD | +4.50% | +40.61% | -17.14% |
Apr. 26 | Foreign automakers eager for Chinese partners at Beijing auto show | RE |
Apr. 25 | Battle for 'tech luxury' in China as EVs get smarter - and cheaper | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.14% | 168M | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Seres Therapeutics Appoints Marella Thorell as Executive Vice President